^
    No biomarker
    Thymoma
    GEM-CAP
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    LV5FU2
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    CaT
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    VIP
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    CAP
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    etoposide IV
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    ifosfamide
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    CAP + prednisone
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    ADOC
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    EP
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    carboplatin
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    pembrolizumab
    Resistant: A2 - Guideline
    No biomarker
    Thymoma
    gemcitabine
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    paclitaxel
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    pemetrexed
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    prednisone + octreotide
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    octreotide
    Sensitive: A2 - Guideline
    No biomarker
    Thymoma
    everolimus
    Sensitive: A2 - Guideline
    IGF1R expression
    Thymoma
    everolimus
    Resistant: C3 – Early Trials
    EIF4EBP1 expression
    Thymoma
    everolimus
    Resistant: C3 – Early Trials
    PD-L1 overexpression
    Thymoma
    pembrolizumab
    Sensitive: C4 – Case Studies